Latest Funds From Operations News

Zelira Therapeutics reports promising diabetic neuropathy study results with ZLT-L-007 surpassing Lyrica, while converting $3.25 million in notes to equity to bolster HOPE® 1 clinical development.

Volt Resources reports robust progress on its Alabama Graphite Refinery scoping study, strategic partnerships in Tanzania, and resilient production in Ukraine, positioning itself strongly amid evolving graphite market dynamics.

Garda Property Group’s FY25 results reveal a strategic pivot with significant asset sales and a sharp reduction in gearing, setting the stage for an 11% rise in distributions in FY26.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.

Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.

Garda Property Group reported a 4.3% rise in revenue and a significant reduction in losses for FY25, alongside a modest decline in net tangible assets per security. Investors welcomed the return of dividends after a year without payouts.

Acrux Limited reports promising revenue growth driven by new topical generic launches in the US and secures crucial RDTI funding, marking a strategic shift under new CEO John Warmbrunn.

VanEck Global Defence ETF, launched in September 2024, has reported a solid AUD 2.8 million profit in its first interim financial results ending January 2025, marking a promising start for the defence-focused fund.

Vulcan Energy Resources reported significant cash outflows in the June 2025 quarter driven by exploration and development, yet maintains a robust liquidity position with nearly €49 million in cash and a €10 million credit facility.

McLaren Minerals reported a net cash outflow in operating and investing activities for Q2 2025 but bolstered its cash reserves with a $1.282 million placement to support advancing feasibility studies.

Holista Colltech reported steady customer receipts and a 38% surge in dietary supplement sales for 2QFY25, while progressing its high-value nano-collagen business and refreshing its leadership team.

Gullewa Limited reported a solid cash balance of A$8.1 million at the end of June 2025, supported by positive operating cash flow despite ongoing investment in exploration and corporate activities.